You are here

Our science / Clinical Trials / Find a Trial / NCT01220180

Lyrica (Pregabalin) Korean Post Marketing Surveillance Study

Back to Search Print Save as PDF Bookmark Trial

NCT01220180

Last updated on March 14, 2019
Back to Search Print Save as PDF Bookmark Trial

FOR MORE INFORMATION
Study Location
Contact
1-800-718-1021
[email protected]
Related Links
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Epilepsy, Neuropathic Pain, Fibromyalgia, Post-market Surveillance
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
0 +
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Any patient treated with pregabalin for an approved indication by Korean Food and Drug
Administration

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Non-consenting

- Hypersensitivity to the active substance or to any of the excipients

- galactose intolerance, Lapp lactase deficiency or glucose-galactose malabsorption.

NCT01220180
Pfizer
Completed
Lyrica (Pregabalin) Korean Post Marketing Surveillance Study

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.
Advanced Search

Based on your search, you may also be interested in

Partial Seizures Epilepsy, Primary Generalized Tonic-Clonic Seizures Epilepsy
A 12-Month Study To Evaluate The Safety And Tolerability Of Pregabalin As Add-On Therapy In Pediatric Subjects 1 Month To 16 Years Of Age With Partial Onset Seizures And Pediatric And Adult Subjects 5 To 65 Years Of Age With Primary Generalized Tonic-Clonic Seizures
NCT01463306
All Genders
0+
Years
Multiple Sites

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now